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OUTCOME OF ENDOSCOPIC THERAPEUTIC INTERVENTIONS: ARE
THEY DIFFERENT AMONG VARIOUS NON- MALIGNANT
ESOPHAGEAL DISEASES
Rustam Khan, Shahab Abid, Saeed Hamid, Zaigham Abbas, Hasnain Shah, Wasim Jafri
Section of Gastroenterology, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan

Background: This study was carried out to evaluate and compare the outcome of various causes
of non-malignant lesions of the esophagus after endoscopic therapeutic intervention. Methods: A
cohort of patients with non-malignant dysphagia presenting at Aga Khan University hospital, a
tertiary care setting who underwent endoscopic intervention was studied. Response to treatment
was evaluated by improvement in dysphagia score on a scale of 0-4 and weight gain. Results: 99
subjects (53 males) were included. Mean age was 48.6±17.2 years. Dysphagia for solids was
present in 48%, for liquids in 3% and for both in 49% patients. Significant weight loss (>10%
body weight) occurred in 35 (35.3%) patients. Achalasia was diagnosed in 49.5%, peptic stricture
in 30.4%, post sclerotherapy stricture in 12.1%, corrosive injury in 4%, post-operative stricture in
4%. In comparative analysis of achalasia and inflammatory groups, good response to dysphagia
was seen in 40/49 (82%) and 22/50 (44%) respectively p < 0.001. Weight gain was 35/49 (72%)
and 22/50 (44%) p <0.001 respectively. Significantly, more endoscopic sessions were required in
inflammatory group compare to achalasia; 2.2 and 1.1 respectively; p <0.001 and 16%
complications rate in inflammatory group comparing to no complications in achalasia.
Conclusions: Dysphagia and weight loss were common presentations in non-malignant
esophageal diseases. Therapeutic intervention in inflammatory group was associated with high
complication than the achalasia group.
Key words: outcome of non-malignant esophageal diseases, Benign esophageal lesions,
Achalasia, esophageal strictures.

INTRODUCTION
Dysphagia and weight loss are manifestations of
various esophageal diseases. This includes both
malignant and non-malignant conditions. Among the
malignant lesions, carcinoma of esophagus is the
commonest cause1 and in non-malignant lesions,
peptic stricture and achalasia are relatively common
causes.2 Therapeutic approaches and outcome in
terms of overall survival are different in nonmalignant conditions from the malignant. Moreover,
there is a gross variability in response to endoscopic
therapeutic intervention in patients even within
various non-malignant esophageal lesions. This
variability in the response among various nonmalignant esophageal diseases was never compared.
This study was aimed to evaluate and compare the
outcome of the patients with different causes of nonmalignant esophageal lesions presented with
dysphagia and weight loss after therapeutic
endoscopic interventions.

MATERIAL AND METHODS
During the study period from January 1999 till
December 2001, patients with dysphagia and weight
loss were evaluated. Those who fulfil the criteria
were enrolled for intervention and followed up for
long-term outcome after therapeutic interventions.

Patients aged more than 18 years with symptoms
of dysphagia and weight loss who had benign
esophageal lesion on investigations were included.
While patients with malignant esophageal or gastric
lesions, central neurological causes of dysphagia,
systemic illnesses accounting for weight loss e.g.
diabetes mellitus, collagen vascular disease etc,
extrinsic structural lesions of the neck and chest
causing compression, pregnancy and esophageal
varices were excluded.Similarly patients who were
not fit for endoscopic intervention were also
excluded.
Weight loss was considered significant if the loss
was more than 10% of body weight in six months
prior to presentation. Clinical history and physical
examination were done to exclude non-esophageal
causes of weight loss. These patients then underwent
barium swallow followed by endoscopic procedures.
Diagnosis of the non-malignant lesions were based
on histology if required, relevant history of corrosive
ingestion, sclerotherapy, acid peptic disease etc.
Achalasia was diagnosed on barium esophagogram
and endoscopic findings. Endoscopic procedure was
done in conscious sedation after taking informed
consent. Sedation used was midazolam 2-5 mg until
the patient was relaxed and fully sedated. Procedures
were done under fluoroscopic guidance. For achalasia
graded dilatation with pneumatic balloon 30 mm to
35 mm was done for 60-90 seconds. For
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inflammatory strictures Savary-gilliard dilator 5-17
mm were used for dilatation. Immediate
complications if any were noted.
Patients were followed in clinics for one year.
Response to treatment was evaluated on 1st post
procedure visit after one week by physician not
involved in the procedure. Improvement was
evaluated by subjective improvement in dysphagia
Score 0 - 4; where score 4 meant best response with
no dysphagia. Score 3 mild dysphagia for solids,
Sscore 2 where patient could only swallow semi solid
things, Score 1 liquid only and score 0, complete
dysphagia. Patient’s weight was also recorded on
follow up visits and best weight in six months after
procedure was taken. Patients with peptic stricture
were continued on proton pump inhibitors after
procedure.

RESULTS
Ninety-nine patients (53 males) were eligible for
analysis (Table 1 & 2). Mean age was 48.6±17.2
years. Dysphagia for solids was present in 48%, for
liquids in 3% and for both in 49% patients. All
patients had history of weight loss but 35 (35.5%) of
them had significant loss of weight. Total numbers of
161 dilatation session were done in 99 patients. With
mean of 1.5 sessions per patient this includes;
pneumatic balloon dilatation 35% and Savory
Gilliard dilators 65%. In comparative analysis of
achalasia and inflammatory groups (table 3), good
response to dysphagia (score 4) was seen in 40/49
(82%) and 22/ 50 (44%) respectively p < 0.001.
Weight gain was 35/49 (71%) and 22/50 (44%) p <
0.001 respectively.
These patients were followed-up for mean of
322 days ± 88 days. Number of endoscopic sessions
during the follow-up period were more in
inflammatory group compared to achalasia group; 2.2
(range 1 – 8) vs. 1.1(range 1 – 2). P < 0.001. In
inflammatory group, 8/50 (16%) patients had
complications comparing to no complications in
achalasia. These complications were perforation in
6(12%), bleeding requiring transfusion in one patient
and local abscess in another patient. Among the
patients who had perforation, 3/6 had underlying post
corrosive stricture and in another three patients,
underlying pathology was peptic stricture. Four
patients
with
perforation
were
managed
conservatively and improved.
One 50 years old female patient with peptic
stricture had perforation underwent surgery for
repair and another patient with post corrosive
stricture died following perforation due to
mediastinitis and sepsis.

Table-1: Patient characteristics (n = 99)
Patient’s characteristic
Male
Female
Mean age
Dysphagia for solids
Dysphagia for liquids
Both solids and liquids
Significant weight loss
(>10 % body weight in 6
months)
Therapeutic interventions
1. Pneumatic balloon
dilatation sessions
2. Savary Gilliard
dilatation
Total no of procedures

Achalasia Inflammatory
(n 49)
(n 50)
28 (57%)
26 (52%)
21 (43%)
24 (48%)
45.5 ± 15.3 51.7 ± 18
26 (53%)
22 (44%)
1 (2%)
2 (4%)
22 (45%)
26 (52%)
16(32. %)

19(38%)

49 (100%)

-

-

50 (100%)

163

Mean 1.5

DISCUSSION
Achalasia, inflammatory strictures and esophageal
webs and schatzki’s rings are all different but benign
entities. They all present with dysphagia and weight
loss and treated with therapeutic endoscopic
interventions.1,2 Successful outcome after therapeutic
intervention may be measured by pressure changes in
the esophagus, height and width of barium column
measured on radiograph and rate of esophageal
emptying in these patients. However the mainstay of
success is improvement in dysphagia and weight
gain,3-5 same parameters are used in this study.
Clinical parameters in this series has shown an
overall good response to endoscopic treatment in
64% patients in terms of dysphagia and 57% patients
had significant
weight gain after therapeutic
interventions.
Several options are available for treatment
of achalasia. Pneumatic balloon dilatation is effective
and economical method with low complications1
rates. Graded dilatation was proved safer if procedure
begins with 30 mm balloon, good to excellent
response was seen up to 77% patients, moderate
response in 12% patients in long-term follow-up for
3-12 years.4 In another study good to excellent
response to pneumatic dilatation and Heller’s
myotomy was found comparable i.e. 88% vs. 89 % if
skilled operators were available.11 In the present
series of 49 achalasia patients, good response to
dysphagia was seen in 40(82%) patients and 35(72%)
patients gained significant weight after dilatation
procedures. Only one patient required Heller’s
myotomy because of poor response to pneumatic
balloon dilatation. In literature incidence of
esophageal rupture with pneumatic balloon dilatation
is reported between 0-12 percent and none of the
patient in this series had this complication.10, 11
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Table-2: Pathological Diagnosis and complications
Pathology

n (%)

Perforation

Achalasia

49 (49.5%)

-

Peptic stricture
Post sclerotherapy stricture

30 (30.45%)
12 (12.1%)

3
-

4 (4%)
4 (4%)

3

Post surgical stricture
Post corrosive ingestion

Bleeding

٭

Local abscess

-

-

٭

1

-

-

1
-

 ٭Significant bleeding requiring transfusion.
Table-3: Response and complications in Achalasia and inflammatory groups.
Characteristics
Good response.
Mild to moderate response.
Poor response.
Significant weight gain.
Average no. of sessions
Complications.

Achalasia group (n = 49)
(n).
(%)
95 % C. I
40
8
1
35
1.1±0.3*
0

(82)
(16)
(2)
(72)
--

70-92
6 - 26
0-6
75 - 95
0.59-1.57°
--

Inflammatory group n = 50
(n)
(%)
95 % C.I
22
18
10
22
2.2±1.7*
8

(44)
(36)
(20)
(44)
(16)

27 – 60
19 – 51
7 – 34
27 – 60
0.59-1.57°
--

P. Value

< 0.001
< 0.001
< 0.001

n = number; % = percentage; C.I = confidence interval;* = mean with standard deviation;
° = 95 % C.I of difference of means.
In an average of 1.1 ± 0.3 sessions were
required for achalasia patients in the present series
which is comparable to other published series.1-6
Benign esophageal stricture is a serious
complication of gastroesophageal reflux disease 12, 13.
Response to treatment depends upon the size and
nature of the stricture and patient selection. These
patients require 1-9 dilatation sessions in a year and
these sessions can be reduced by concomitant use of
omeprazol 14, 15. If these patients do not respond to
dilatation procedures then surgical option are
considered. 14, 15. Fluoroscopic guided balloon
dilatation is accepted standard treatment of
esophageal stricture dilatation. mortality and
morbidity was less in dilatation with bougies than
surgery 16, 17. Incidence of esophageal rupture has
been reported between 12-32 % by dilatation with
balloon or bougies 18,19,20.In a study 153 patients who
underwent 1043 dilatation procedure without
fluoroscopy with Savary Gilliard, bougies and
endoscopically oriented balloon. Good response was
seen in 65.5% patients, perforation rate was 2.8% and
mortality was 0.7 %24. In our series of 50 patients
with inflammatory strictures who underwent
dilatation procedure under fluoroscopic guidance
with Savary Gilliard dilators (5-17 mm), good
response was seen in 22 (44%) patients. An average
of 2.2± 1.7 session range from 1-8 were required to
achieve the response during the follow-up period. In
the inflammatory group six (12%) patients had
perforations following endoscopic dilatation. Four of
them improved on conservative management and one

patient with peptic stricture required surgery for
repair of perforation. Another patient with post
corrosive stricture died following perforation due to
mediastinitis and sepsis. Among the patients who had
complications, 3/6 patients had underlying post
corrosive stricture and in other three patients, peptic
stricture was the underlying etiology.
Comparison of achalasia and inflammatory
stricture in term of response to endoscopic dilatations
and complications revealed that although both groups
were similar in manifestation and are non-malignant
conditions but response to treatment was significantly
better in achalasia than in inflammatory strictures
because of apparent difference in the underlying
diseases. Moreover the number of therapeutic
endoscopic session during the follow-up period were
significantly more in inflammatory sub-group
compared to achalasia group; 2.2 and 1.1 respectively
p<0.001.
In conclusion, dysphagia and weight loss
were common symptoms in non-malignant
esophageal lesions. Majority of patients showed
significant improvement following endoscopic
intervention. Response to endoscopic intervention,
number of therapeutic endoscopic sessions and
frequency of complication in achalasia patients were
significantly better than inflammatory stricture.
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